arrow
I

Ichiro Hanamura

Aichi Medical University
H指数:23
被引数:5,912

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Nintedanib inhibits the VEGFR–ERK signaling pathway in human KRAS-mutated cancer cells

尼达尼布抑制人KRAS突变癌细胞中的VEGFR–ERK信号通路

2026-06-230
OAAI
Ascophyllan Supplementation Is Safe and Associated with Exploratory Modulation of Innate Immune Phenotypes, Biochemical Parameters, and the Gut Microbiome in a Randomized Pilot Trial

Ascophyllan补充剂是安全的,并与初步调节固有免疫表型、生化参数及肠道微生物组相关:一项随机初步试验

2026-06-150
OA
Targeting fatty acid synthase suppresses tumor development in NF2/CDKN2A-deficient pleural mesothelioma

靶向脂肪酸合酶可抑制NF2/CDKN2A缺陷型胸膜间皮瘤的肿瘤发生

2026-02-280
OAAI
A case of fatal Cupriavidus gilardii sepsis following cord blood transplantation: Pitfalls of novel antimicrobial agents

1例铜绿假单胞菌(Cupriavidus gilardii)败血症致死病例:新型抗菌药物的陷阱

2026-01-290
OAAI
ARK5 enhances cell survival associated with mitochondrial morphological dynamics from fusion to fission in human multiple myeloma cells

ARK5增强与人多发性骨髓瘤细胞从融合到分裂的线粒体形态动力学相关的细胞存活

2024-01-295
OAAI
Changing trends in the risk factors for second primary malignancies after autologous stem cell transplantation for multiple myeloma before and after the introduction of proteasome inhibitors and immunomodulatory drugs
2023-07-201
OAAI
CD52 is a novel target for the treatment of FLT3-ITD-mutated myeloid leukemia
2021-05-257
OAAI